Effect of Alloiococcus otitidis and three pathogens of otitis media in production of interleukin-12 by human monocyte cell line

FEMS Immunology and Medical Microbiology

Volumn 29, Issue 2, 2000, Pages 101-106

  Himi, Tetsuo ^a   Kita, Hideaki ^a   Mitsuzawa, Hiroaki ^a   Harimaya, Atsushi ^a   Tarkkanen, Jussi ^b   Hendolin, Panu ^c   Ylikoski, Jukka ^c   Fujii, Nobuhiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alloiococcus otitidis; Interleukin 12; Monocyte; Otitis media

Indexed keywords

INTERLEUKIN 12;

ARTICLE; CONTROLLED STUDY; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; MONOCYTE; MORAXELLA CATARRHALIS; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTIGENS, BACTERIAL; CELL LINE; DIFFUSION CHAMBERS, CULTURE; FIXATIVES; GLUTARAL; HUMAN; INTERLEUKIN-12; LACTOBACILLACEAE; MONOCYTES; OTITIS MEDIA; SUBCELLULAR FRACTIONS; SUPPORT, NON-U.S. GOV'T;

EID: 0033829063     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(00)00193-0     Document Type: Article

References (21)

1. Hendolin P.H., Markkanen A., Ylikoski J., Wahlfors J.J. Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions. J. Clin. Microbiol. 35:1997;2854-2858.
2. Hendolin P., Karkkainen U., Himi T., Markkanen A., Ylikoski J. High incidence of Alloiococcus otitis in otitis media with effusion. Pediatr. Infect. Dis. J. 18:1999;860-865.
3. Faden H., Dryja D. Recovery of a unique bacterial organism in human middle ear fluid and its possible role in chronic otitis media. J. Clin. Microbiol. 27:1989;2488-2491.
4. Aguirre M., Collins M.D. Development of a polymerase chain reaction-probe test for identification of Alloiococcus otitis. J. Clin. Microbiol. 30:1992;2177-2180.
5. Beswick A., Lawley B., Fraise A., Pahor A., Brown N. Detection of Alloiococcus otitis in mixed bacterial populations from middle-ear effusions of patients with otitis media. Lancet. 354:1999;386-389.
6. Rayner M.G., Zhang Y., Gorry M.C., Chen Y., Post J.C., Ehrlich G.D. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. J. Am. Med. Assoc. 279:1998;296-299.
7. Harty J.T., Lenz L.L., Bevan M.J. Primary and secondary immune responses to Listeria monocytogenes. Curr. Opin. Immunol. 8:1996;526-530.
8. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., Murphy K.M. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 260:1993;547-549.
9. Conlan J.W., North R.J. Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium. J. Exp. Med. 174:1991;741-744.
10. Tripp C.S., Gately M.K., Hakimi J., Ling P., Unanue E.R. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-γ J. Immunol. 152:1994;1883-1887.
11. Song F., Matsuzaki G., Mitsuyama M., Nomoto K. Differential effects of viable and killed bacteria on IL-12 expression of macrophages. J. Immunol. 156:1996;2979-2984.
12. Tripp C.S., Kanagawa O., Unanue E.R. Secondary response to Listeria infection requires IFN-γ but is partially independent of IL-12. J. Immunol. 155:1995;3427-3432.
13. Derrico C.A., Goodrum K.J. Interleukin-12 and tumor necrosis factor α mediate innate production of γ interferon by group B Streptococcus-treated splenocytes of severe combined immunodeficiency mice. Infect. Immun. 64:1996;1314-1320.
14. Cleveland M.G., Gorham J.D., Murphy T.L., Tuomanen E., Murphy K.M. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1996;1906-1912.
15. Miller M.A., Skeen M.J., Ziegler H.K. Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12. Cell. Immunol. 184:1998;92-104.
16. D'Andrea A., Rengaraju M., Valiante N.M. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1992;1387-1398.
17. Ma Y., Seiler K.P., Tai K.F., Yang L., Woods M., Weis J.J. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect. Immun. 62:1994;3663-3671.
18. Halpern M.D., Kurlander R.J., Pisetsky D.S. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α Cell. Immunol. 167:1996;72-78.
19. Noll A., Autenrieth Ib. Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect. Immun. 64:1996;2955-2961.
20. Gazzinelli R.T., Wysocka M., Hayashi S. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:1994;2533-2543.
21. Miller M.A., Skeen M.J., Ziegler H.K. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155:1995;4817-4828.